Aptorum Group Limited: Aptorum Group Launches NativusWell, a Novel Nutraceutical for Menopause, in China

Regulatory News: Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) ("Aptorum Group"), a clinical-stage biopharmaceutical company focused on the development of novel therapeutics to tackling

Related Keywords

China ,United States ,Jingdong ,Guangdong ,United Kingdom ,Singapore ,Dennis Riedl ,Craig Brelsford ,Ghislaine Gasparetto ,Aptorum Group Form ,Investor Relations Department ,Singapore Agency For Science ,Actifin Financial Communications Europe ,Redchip Financial Communications United States ,Daptorum Group ,Aptorum Group Limited Nasdaq ,Regulatory News ,Group Limited ,Euronext Paris ,Mol Struct ,Food Sci ,Aptorum Group Limited ,Securities Litigation Reform Act ,French Autorit ,Des March ,Regulations Delegated ,Relations Department ,Financial Communications United States ,Financial Communications Europe ,Aptorum ,Group ,Imited ,Aunches ,Ativuswell ,Novel ,Utraceutical ,Menopause ,